pyridine has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
azine : An organonitrogen compound of general structure RCH=N-N=CHR or RR'C=N-N=CRR'.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Especially, lung cancer is one of the most common causes of cancer-related mortality accounting for approximately 15% of all cancer cases worldwide." | 2.61 | A Review on the Antitumor Activity of Various Nitrogenous-based Heterocyclic Compounds as NSCLC Inhibitors. ( Liu, JC; Narva, S; Zhang, W; Zhou, K, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fatima, S | 1 |
| Pal, D | 1 |
| Agarwal, SM | 1 |
| Liu, JC | 1 |
| Narva, S | 1 |
| Zhou, K | 1 |
| Zhang, W | 1 |
1 review available for pyridine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
A Review on the Antitumor Activity of Various Nitrogenous-based Heterocyclic Compounds as NSCLC Inhibitors.
Topics: Antineoplastic Agents; Azoles; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Drug Resistance, | 2019 |
1 other study available for pyridine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
QSAR of clinically important EGFR mutant L858R/T790M pyridinylimidazole inhibitors.
Topics: Carcinoma, Non-Small-Cell Lung; Drug Design; ErbB Receptors; Humans; Imidazoles; Inhibitory Concentr | 2019 |